NCT04440267
- Conditions
- Acute Leukemia of Ambiguous Lineage, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- HBDH Tianjin, Tianjin Municipality, China
Clinical trial condition
Acute Leukemia of Ambiguous Lineage
Explore clinical trials studying Acute Leukemia of Ambiguous Lineage. Study availability and eligibility vary by location and protocol.
20 public trials
12 recruiting studies
Acute Leukemia of Ambiguous Lineage trial results
NCT06355583
- Conditions
- Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukaemia, Acute Myeloid Leukemia, +27 more
- Locations
-
- University Hospitals Birmingham NHS Foundation Trust Birmingham, England, United Kingdom
- Leeds Teaching Hospital NHS Trust Leeds, England, United Kingdom
- University College London Hospitals NHS Trust London, England, United Kingdom
- Kings College NHS Foundation Trust London, England, United Kingdom
Not Yet Recruiting
Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment
NCT07636564
- Conditions
- Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, +24 more
- Locations
-
Not specified
NCT02220985
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
- Locations
-
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT02828358
- Conditions
- Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +21 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
NCT02135874
- Conditions
- Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +16 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01858740
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +41 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03012672
- Conditions
- Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Hematologic Diseases, +13 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01319864
- Conditions
- ALL, AML, Acute Leukemia of Ambiguous Lineage, +20 more
- Locations
-
- Phoenix Children's Hospital Phoenix, Arizona, United States
- The Children's Hospital of Denver Denver, Colorado, United States
- Children's Healthcare of Atlanta/Emory University Atlanta, Georgia, United States
- Johns Hopkins Medical Center Baltimore, Maryland, United States
Active, Not Recruiting
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
NCT04067336
- Conditions
- Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +20 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- UCLA Ronald Reagan Medical Center Los Angeles, California, United States
- Mayo Clinic Jacksonville, Florida, United States
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois, United States